U.S. President Donald Trump has issued an executive order aiming to reduce childhood vaccinations by streamlining the immunization schedule to 11 shots, emphasizing enhanced protection for American children and aligning with other countries that advocate for fewer vaccinations. This order reflects the longstanding objective of Health Secretary Robert F. Kennedy Jr., a vocal critic of vaccines who has propagated a discredited association between vaccines and autism. Notably, the executive order proposes dividing the childhood MMR (measles, mumps, and rubella) vaccine into three separate doses administered at different medical appointments.
Earlier this year, Kennedy had modified the U.S. immunization schedule by eliminating vaccines for six out of 17 diseases, a decision that was later overturned by a federal court ruling. The current executive order stipulates that the federal government will only endorse the remaining 11 vaccinations. While the order suggests updated vaccine guidelines, it highlights that individual states retain the authority to mandate vaccinations for school children. The directive advises states with existing school vaccine requirements to consider revising their laws to align with the administration’s preferred vaccination timeline.
Governor Kevin Stitt of Oklahoma, a Republican, commended the order for enhancing clarity and transparency in vaccine recommendations. However, Democratic governors J.B. Pritzker of Illinois and Josh Shapiro of Pennsylvania criticized the order, with Pritzker expressing concerns about the potential spread of misinformation leading to a rise in measles cases. The order further instructs the Justice Department to legally challenge state vaccination laws that conflict with parental rights, religious freedoms, disability accommodations, and equal protection, including regulations on religious and medical exemptions from vaccine mandates.
Medical associations, public health experts, and pharmaceutical companies have also expressed reservations about the executive order. Dr. Aaron Milstone from the American Academy of Pediatrics Committee on Infectious Diseases warned of potential confusion among parents due to conflicting messages, which could result in delays in vaccination. Merck, a major pharmaceutical company, emphasized that there is no scientific evidence supporting the efficacy of splitting the MMR vaccine into three doses, cautioning that this approach could lead to missed or delayed immunizations.
Critics have raised concerns about the feasibility and implications of the proposed changes, particularly questioning the availability of single-antigen measles, mumps, and rubella vaccines in the United States. Dr. Elizabeth Mack, a pediatric critical care physician, highlighted logistical challenges such as increased medical visits and reimbursement issues for parents. Mike Ybarra, the chief medical officer of the pharmaceutical lobby group PhRMA, stressed the importance of evidence-based decision-making in revising vaccination schedules.
Despite the executive order’s intentions, opposition from various quarters, including Republican Senator Bill Cassidy, who chairs the Senate health committee and disapproves of the order, has underscored the contentious nature of the vaccination debate. Autism experts and the World Health Organization have reiterated the importance of evidence-based vaccination schedules, emphasizing decades of research supporting the current immunization guidelines. Trump’s administration, Kennedy, and White House officials have defended the order, asserting that it will significantly reduce the number of injections received by American children compared to previous recommendations.